The preliminary screening revealed that melosuavine I treatment resulted in the induction of apoptosis by stimulating the p53 expression and inhibiting the Bcl-2 level, in addition to the activation of the anti-proliferation effect in breast cancer cells [115]. Here, TP53 is linked to breast carcinoma.